[1] Popov SS, Pashkov AN, Popova TN, et al. Melatonin influence on free radical homeostasis in rat tissues at thyrotoxicosis[J]. Biomed Khim, 2008, 54(1):114-121. [2] Paulis L, Simko F. Blood pressure modulation and cardiovascular protection by melatonin:potential mechanisms behind[J]. Physiol Res, 2007, 56(6):671-684. [3] 景会锋. 有氧运动和褪黑素对2型糖尿病大鼠抗氧化运动功能的影响[J]. 中国应用生理学杂志, 2014, 30(5):426-428. [4] Tunstall RR, Shukla P, Grazul-Bilska A, et al. MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries[J]. J Pharmacol Exp Ther, 2011, 336(1):127-133. [5] 邱方, 熊开宇, 石丽君. 褪黑素在有氧运动改善自发性高血压大鼠血压和肠系膜动脉功能中的作用[J]. 中国动脉硬化杂志, 2015, 23(12):1229-1235. [6] 杨玉雯, 阚敬保, 孔祥权. BKCa增龄变化及其与血压的相关性[J]. 中国应用生理学杂志, 2009, (4):511-515. [7] Suh EY, Yin MZ, Lin H, et al. Maxi-K channel (BKCa) activity veils the myogenic tone of mesenteric artery in rats[J]. Physiol Rep, 2017, 5(14):e13330. [8] 李先明, 秦涛. 褪黑素在心血管疾病中的研究进展[J]. 中西医结合心血管病电子杂志, 2016, 4(14):7-9. [9] Geary GG, Krause DN, Duckles SP. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels[J]. Am J Physiol, 1997, 273(3 Pt 2):H1530-1536. [10] Regrigny O, Delagrange P, Scalbert E, et al. Effects of melatonin on rat pial arteriolar diameter in vivo[J]. Br J Pharmacol, 1999, 127(7):1666-1670. [11] Geary GG, Duckles SP, Krause DN. Effect of melatonin in the rat tail artery:role of K+ channels and endothelial factors[J]. Br J Pharmacol, 1998, 123(8):1533-1540. [12] Lew MJ, Flanders S. Mechanisms of melatonin-induced vasoconstriction in the rat tail artery:a paradigm of weak vasoconstriction[J]. Br J Pharmacol, 1999, 126(6):1408-1418. [13] Girouard H, Chulak C, Lejossec M, et al. Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats[J]. J Hypertens, 2001, 19(8):1369-1377. [14] Fish JE, Marsden PA. Endothelial nitric oxide synthase:insight into cell-specific gene regulation in the vascular endothelium[J]. Cell Mol Life Sci, 2006, 63(2):144-162. [15] Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease:from marvel to menace[J]. Circulation, 2006, 113(13):1708-1714. [16] Anwar MM, Meki AR, Rahma HH. Inhibitory effects of melatonin on vascular reactivity:possible role of vasoactive mediators[J]. Comp Biochem Physiol C Toxicol Pharmacol, 2001, 130(3):357-367. [17] Das R, Balonan L, Ballard HJ, et al. Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery[J]. Int J Cardiol, 2008, 126(3):340-345. [18] Yu H, Dickson EJ, Jung SR, et al. High membrane permeability for melatonin[J]. J Gen Physiol, 2016, 147(1):63-76. [19] Pandi-Perumal SR, Bahammam AS, Ojike NI, et al. Melatonin and human cardiovascular disease[J]. J Cardiovasc Pharmacol Ther, 2017, 22(2):122-132. |